Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00098618
What this trial is testing

Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaPapillary Renal Cell CarcinomaRecurrent Renal Cell Cancer+2 more
National Cancer Institute (NCI) 40
Not applicableNot Yet RecruitingNCT07065825
What this trial is testing

Tumor Rupture During Robotic Partial Nephrectomy

Who this might be right for
Kidney CancerRenal Neoplasms
Azienda Ospedaliera Universitaria Integrata Verona 100
Testing effectiveness (Phase 2)Study completedNCT02431676
What this trial is testing

Survivorship Promotion In Reducing IGF-1 Trial

Who this might be right for
Breast CancerProstate CancerLung Cancer+8 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 121
Not applicableUnknownNCT00980317
What this trial is testing

A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties

Who this might be right for
Kidney NeoplasmsRenal InsufficiencyRenal Replacement Therapy
Tokushukai Medical Group 5
Testing effectiveness (Phase 2)Study completedNCT00003390
What this trial is testing

6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00002847
What this trial is testing

Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Blumenthal Cancer Center at Carolinas Medical Center 14
Early research (Phase 1)UnknownNCT00314925
What this trial is testing

Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features

Who this might be right for
CarcinoidNeuroendocrine
Neotropix 60
Early research (Phase 1)Ended earlyNCT01677390
What this trial is testing

A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Seagen Inc. 4
Very early researchWithdrawnNCT02671552
What this trial is testing

Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery

Who this might be right for
Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableUnknownNCT05439538
What this trial is testing

Serum NGAL IN Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma(MM)
Assiut University 60
Testing effectiveness (Phase 2)Ended earlyNCT06114940
What this trial is testing

Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO)

Who this might be right for
Renal Cell Carcinoma (RCC)
Jinling Hospital, China 17
Not applicableActive Not RecruitingNCT06195150
What this trial is testing

Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaVHL Syndrome
IRCCS San Raffaele 3
Testing effectiveness (Phase 2)Ended earlyNCT04902040
What this trial is testing

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Who this might be right for
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
M.D. Anderson Cancer Center 19
Early research (Phase 1)Active Not RecruitingNCT04388852
What this trial is testing

DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+7 more
M.D. Anderson Cancer Center 65
Not applicableEnded earlyNCT01507740
What this trial is testing

Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients

Who this might be right for
Hepatocellular CancerNon-small Cell Lung CancerRenal Cell Cancer+1 more
Medical University Innsbruck 60
Testing effectiveness (Phase 2)Ended earlyNCT01239342
What this trial is testing

Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer

Who this might be right for
Metastatic Kidney CarcinomaRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 43
Early research (Phase 1)Looking for participantsNCT05873686
What this trial is testing

Clinical Study of NXP900 in Subjects With Advanced Cancers

Who this might be right for
Advanced Solid TumorNSCLC (Non-small Cell Lung Cancer)Renal Cancer+3 more
Nuvectis Pharma, Inc. 140
Not applicableUnknownNCT05135520
What this trial is testing

Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised Kidney Specimen

Who this might be right for
Urologic Neoplasms
Seoul National University Bundang Hospital 106
Not applicableLooking for participantsNCT07294859
What this trial is testing

Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy

Who this might be right for
NephrectomyRenal Cell CancerAKI - Acute Kidney Injury
Jinling Hospital, China 285
Not applicableEnded earlyNCT00289146
What this trial is testing

Comparison of Immune Response Following Surgical Management of Renal Tumors

Who this might be right for
Kidney Cancer
Emory University 50
Next Page